Supplier

BRISTOLMYERS SQUIBB SPOL S RO

Value won

CZK 129.9m

Across 1 contract won

A Czech Republic supplier, with 1 awarded contract, most recently 14 months ago.

Czech Republic(inferred)

Value won

CZK 129.9m

Across 1 contract won

Contract history

1 entry

9 June 2025

14 months ago · Won · £129,879,212 · Supply of Antineoplastic Drugs Containi…

Opportunities

Showing awarded · 1

AwardedHealthcare & MedicalCzech Republic

Supply of Antineoplastic Drugs Containing Nivolumab and Relatlimab

This public procurement contract involves the ongoing supply of pharmaceutical products containing the active ingredients nivolumab and relatlimab. The contract is valued at approximately 129.9 million euros and is intended for the health sector. The buyer is the Faculty Hospital in Olomouc, Czech R

CZK 129,879,212FACULTY HOSPITAL OLOMOUC

Published 9 Jun 2025